Diabetes drug for adults may help obese youths lose weight

02/4/2013 | Reuters

Severely obese youths who received exenatide injections twice a day for three months lost about 7 pounds more than the placebo group, according to a study in JAMA Pediatrics. Initially approved by the FDA for adults with type 2 diabetes, exenatide showed potential "in terms of weight reduction and cardiovascular risk control," lead author Aaron Kelly said.

View Full Article in:

Reuters

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Manager, Business Conduct
Gilead
Foster City, CA
Product Patent Attorney
Gilead
Foster City, CA
Employment Counsel
Gilead
Foster City, CA
Junior to Mid-Level FDA Associate
Morgan Lewis
Washington, DC
Global Counsel - Advertising and Promotions
Mylan Inc.
Washington, DC